Surgical Indications for Infantile Hemangiomas in the Era of Beta-Blocker Therapy

Infantile hemangioma is the most common vascular tumor of infancy and exhibits a characteristic trajectory of rapid postnatal proliferation followed by slow involution. Therapeutic decisions balance the natural history of spontaneous improvement against functional risk, ulceration, cosmetic impact, and psychosocial burden. Over the past decade, oral propranolol has emerged as first-line therapy for high-risk or complicated lesions, while laser modalities remain useful for ulcerated, residual, or superficial components and for selected anatomic sites. We conducted a focused review of contemporary literature to synthesize comparative outcomes, complications, and practical considerations that inform individualized care. Across diverse study designs, propranolol consistently demonstrates superior rates of complete or near-complete resolution, faster response, and favorable tolerability when appropriately monitored. Laser therapy provides important benefits as primary treatment for thin superficial lesions and as adjunct therapy for residual erythema and telangiectasia after systemic control. Adverse effects with propranolol are generally mild and manageable with careful screening, dosing, and follow-up, whereas laser complications are uncommon when parameters are tailored to lesion depth and skin type. We summarize outcome patterns by lesion location, discuss dosing regimens and wavelength selection, and outline a pragmatic approach to treatment selection that integrates lesion morphology, anatomic risk, caregiver preference, and resource availability. The available evidence supports a stepwise, phenotype-driven algorithm in which observation remains appropriate for low-risk lesions, propranolol is preferred for proliferative or function-threatening disease, and laser is reserved for specific surface-dominant or refractory features. Future work should prioritize standardized outcome measures, location-stratified reporting, and prospective evaluation of combined regimens to optimize long-term functional and cosmetic results.